David C. Goldberg
2013 - Enzo Biochem
In 2013, David C. Goldberg earned a total compensation of $344.1K as Vice President Corporate Development and Interim General Manager, Enzo Clinical Labs at Enzo Biochem, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $65,500 |
|---|---|
| Option Awards | $34,423 |
| Salary | $215,000 |
| Other | $29,183 |
| Total | $344,106 |
Goldberg received $215K in salary, accounting for 62% of the total pay in 2013.
Goldberg also received $65.5K in non-equity incentive plan, $34.4K in option awards and $29.2K in other compensation.
Rankings
In 2013, David C. Goldberg's compensation ranked 10,477th out of 12,286 executives tracked by ExecPay. In other words, Goldberg earned more than 14.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,477 out of 12,286 | 15th |
Division Services | 1,687 out of 1,938 | 13th |
Major group Health Services | 181 out of 198 | 9th |
Industry group Medical And Dental Laboratories | 44 out of 49 | 10th |
Industry Medical Laboratories | 44 out of 49 | 10th |
Source: SEC filing on November 26, 2014.
Goldberg's colleagues
We found four more compensation records of executives who worked with David C. Goldberg at Enzo Biochem in 2013.